Neogen Corporation Investors Alert: Class Action Update Received

Important Update for Neogen Corporation Investors
Neogen Corporation (NASDAQ: NEOG) is currently in the spotlight as investors come to terms with significant losses. Those who have seen losses exceeding $100,000 are urged to pay attention to recent developments regarding class action lawsuits. According to information recently highlighted by ClaimsFiler, there’s a looming deadline for filing lead plaintiff applications as part of the ongoing legal proceedings.
Understanding the Class Action Lawsuit
This class action lawsuit emerges from claims that Neogen and some of its executives failed to disclose critical information during a specific timeframe when many investors made purchases. This lack of transparency violated federal securities laws and left investors at a severe disadvantage.
The Class Period
For those unfamiliar, the class period during which these alleged violations occurred spans from January 5, 2023, to June 3, 2025. During this time, shareholders may be positioned to participate actively in the class action, making it essential for them to understand their rights and potential claims.
Recent Financial Performance
The case has gained traction following an alarming disclosure from Neogen on April 9, 2025, when they reported a notable quarterly revenue decrease of 3.4%, amounting to approximately $221 million. This downturn was attributed to integration issues that have plagued the company, coupled with a revision of its fiscal year 2025 guidance. Notably, the announcement also indicated a significant expected capital expenditure of around $100 million, which has further raised eyebrows among investors.
The News Impact
As a direct consequence of these announcements, Neogen's share price experienced a dramatic decline, dropping by 28% in a single day to close at $5.02 per share after a volume of 47 million shares changed hands. Subsequent disclosures, including an anticipated reduction in EBITDA margins to just the high-teens as of June 4, 2025, have only compounded investor concerns. Following this news, the stock further plummeted an additional 17%, closing at $4.96 per share.
Legal Proceedings Overview
The legal case currently unfolds under the title Operating Engineers Construction Industry & Miscellaneous Pension Fund v. Neogen Corporation, et al., No. 25-cv-00802. This class action aims to address the grievances of investors adversely affected by the alleged misinformation provided by Neogen and its officials.
Seek Guidance for Your Claims
If you are a Neogen Corporation shareholder who fits the criteria of having a substantial loss, it is vital to act swiftly. ClaimsFiler offers valuable resources that can help you navigate these tumultuous waters. They assist retail investors in recovering funds lost due to misleading corporate conduct. Through their platform, shareholders can register to access information on various securities class action settlements, upload portfolio data for notifications about relevant cases, and even seek free evaluations from relevant legal experts.
Connecting with Legal Experts
It is advisable for affected investors to reach out to legal professionals to discuss their potential rights and options under the current legal framework. The lawyers at Kahn Swick & Foti, LLC are equipped to provide necessary guidance and can be contacted directly to answer any inquiries you may have regarding the lawsuit.
About Neogen Corporation
Neogen Corporation is a prominent player in the life sciences arena, known for its innovations designed to address food safety and animal health challenges. As the market evolves, so too does Neogen's commitment to integrating advanced technologies and methodologies in its operations.
Frequently Asked Questions
What is the deadline for filing claims against Neogen Corporation?
The deadline for filing lead plaintiff applications in the class action lawsuit is approaching soon. It is crucial for affected investors to act promptly.
What are the main allegations against Neogen Corporation?
Neogen and its executives are being accused of failing to disclose material information that negatively impacted shareholders, corresponding to violations of federal securities laws.
What should I do if I am a shareholder of Neogen?
If you are a shareholder who has experienced substantial losses, it is advised to seek legal counsel and consider joining the class action suit.
How can ClaimsFiler help me?
ClaimsFiler assists investors in recovering their share of losses through securities class action settlements, provides access to necessary information, and helps in claims submissions.
Where can I get more information about the case?
Investors can visit ClaimsFiler's website to access detailed information regarding the lawsuit and explore their rights as potential claimants.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.